MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 526556 | Name: Fluphenazine Decanoate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Fluphenazine Decanoate is an antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia.

Chemical Structure

Fluphenazine Decanoate
Fluphenazine Decanoate
CAS#5002-47-1

Theoretical Analysis

MedKoo Cat#: 526556

Name: Fluphenazine Decanoate

CAS#: 5002-47-1

Chemical Formula: C32H44F3N3O2S

Exact Mass: 591.3100

Molecular Weight: 591.78

Elemental Analysis: C, 64.95; H, 7.49; F, 9.63; N, 7.10; O, 5.41; S, 5.42

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Fluphenazine Decanoate
IUPAC/Chemical Name
2-[4-[3-[2-(Trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate
InChi Key
VIQCGTZFEYDQMR-UHFFFAOYSA-N
InChi Code
InChI=1S/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3
SMILES Code
CCCCCCCCCC(OCCN1CCN(CCCN2C3=C(C=CC=C3)SC4=CC=C(C(F)(F)F)C=C24)CC1)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 591.78 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Siragusa S, Saadabadi A. Fluphenazine. 2017 Oct 10. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017 Jun-. Available from http://www.ncbi.nlm.nih.gov/books/NBK459194/ PubMed PMID: 29083807. 2: Umino M, Kobayashi R, Nisijima K, Suda S. Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate. Prim Care Companion CNS Disord. 2017 Sep 28;19(5). pii: 16l02078. doi: 10.4088/PCC.16l02078. PubMed PMID: 28972705. 3: Omi T, Mitsui Y, Matsunaga H. Long-acting formulation leading to severe long-term adverse effects: a case report of fluphenazine and persistent extrapyramidal symptoms. J Clin Pharm Ther. 2017 Jul 17. doi: 10.1111/jcpt.12589. [Epub ahead of print] PubMed PMID: 28718220. 4: Lytle S, McVoy M, Sajatovic M. Long-Acting Injectable Antipsychotics in Children and Adolescents. J Child Adolesc Psychopharmacol. 2017 Feb;27(1):2-9. doi: 10.1089/cap.2016.0055. Epub 2017 Jan 23. PubMed PMID: 28112539. 5: Zhao YJ, Lin L, Teng M, Khoo AL, Soh LB, Furukawa TA, Baldessarini RJ, Lim BP, Sim K. Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open. 2016 Feb 5;2(1):59-66. eCollection 2016 Jan. PubMed PMID: 27703755; PubMed Central PMCID: PMC4995551. 6: Wagman JD, Wolfe BA, Schook MW. The effect of fluphenazine decanoate on glucocorticoid production, reproductive cyclicity, and the behavioral stress response in the Persian onager (Equus hemionus onager). Zoo Biol. 2015 Nov;34(6):525-34. doi: 10.1002/zoo.21250. Epub 2015 Oct 22. PubMed PMID: 26491959. 7: Marcus SC, Zummo J, Pettit AR, Stoddard J, Doshi JA. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge. J Manag Care Spec Pharm. 2015 Sep;21(9):754-68. PubMed PMID: 26308223. 8: Chou YH, Chu PC, Wu SW, Lee JC, Lee YH, Sun IW, Chang CL, Huang CL, Liu IC, Tsai CF, Yen YC. A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder. Clin Psychopharmacol Neurosci. 2015 Aug 31;13(2):121-8. doi: 10.9758/cpn.2015.13.2.121. PubMed PMID: 26243837; PubMed Central PMCID: PMC4540044. 9: Doshi JA, Pettit AR, Stoddard JJ, Zummo J, Marcus SC. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge. J Clin Psychopharmacol. 2015 Aug;35(4):442-6. doi: 10.1097/JCP.0000000000000353. PubMed PMID: 26075492. 10: Maayan N, Quraishi SN, David A, Jayaswal A, Eisenbruch M, Rathbone J, Asher R, Adams CE. Fluphenazine decanoate (depot) and enanthate for schizophrenia. Cochrane Database Syst Rev. 2015 Feb 5;(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Review. PubMed PMID: 25654768. 11: Nielsen J, Jensen SO, Friis RB, Valentin JB, Correll CU. Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study. Schizophr Bull. 2015 May;41(3):627-36. doi: 10.1093/schbul/sbu128. Epub 2014 Sep 1. PubMed PMID: 25180312; PubMed Central PMCID: PMC4393684. 12: Uchida H, Suzuki T. Dose and dosing frequency of long-acting injectable antipsychotics: a systematic review of PET and SPECT data and clinical implications. J Clin Psychopharmacol. 2014 Dec;34(6):728-35. doi: 10.1097/JCP.0000000000000065. Review. PubMed PMID: 24781442. 13: Weiss RB, Schook MW, Wolfe BA. Long-acting neuroleptic use for reproductive management of non-domestic ungulates using the domestic goat (Capra hircus) as a model. Zoo Biol. 2014 May-Jun;33(3):204-11. doi: 10.1002/zoo.21125. Epub 2014 Mar 18. PubMed PMID: 24644127. 14: Takashi T, Uchida H, Suzuki T, Mimura M. Effectiveness of saikokaryukotsuboreito (herbal medicine) for antipsychotic-induced sexual dysfunction in male patients with schizophrenia: a description of two cases. Case Rep Psychiatry. 2014;2014:784671. doi: 10.1155/2014/784671. Epub 2014 Jan 27. PubMed PMID: 24587934; PubMed Central PMCID: PMC3921956. 15: Nielssen O, Fukui A, Fawkner L, Walker K. Va'a fakalelei 'atamai: restoring the mind in the Kingdom of Tonga. Australas Psychiatry. 2014 Apr;22(2):183-5. doi: 10.1177/1039856214520792. Epub 2014 Feb 10. PubMed PMID: 24516194. 16: Costello S, Heffron B, Taddei L, Benoit M, Hurt L, Simpson L, Bishop J, Folker-Calderon D, Negrusz A. Quantitation of fluphenazine in equine serum following fluphenazine decanoate administration. J Anal Toxicol. 2013 Oct;37(8):594-9. doi: 10.1093/jat/bkt073. Epub 2013 Aug 28. PubMed PMID: 23986099. 17: Uchida T, Suzuki T, Sakurai H, Tsutsumi C, Den R, Mimura M, Uchida H. Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review. Int Clin Psychopharmacol. 2013 Sep;28(5):261-6. doi: 10.1097/YIC.0b013e328363aa5a. PubMed PMID: 23820334. 18: Stanković Z, Ille T. Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy. Vojnosanit Pregl. 2013 Mar;70(3):267-73. PubMed PMID: 23607237. 19: Kirk Morton N, Zubek D. Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia. J Psychosoc Nurs Ment Health Serv. 2013 Mar;51(3):13-8. PubMed PMID: 23547305. 20: Park EJ, Amatya S, Kim MS, Park JH, Seol E, Lee H, Shin YH, Na DH. Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia. Arch Pharm Res. 2013 Jun;36(6):651-9. doi: 10.1007/s12272-013-0105-7. Epub 2013 Apr 1. Review. PubMed PMID: 23543652.